609 related articles for article (PubMed ID: 32549302)
1. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics.
Antao AM; Tyagi A; Kim KS; Ramakrishna S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549302
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.
Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES
Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
4. The potential roles of deubiquitinating enzymes in brain diseases.
Lim KH; Joo JY; Baek KH
Ageing Res Rev; 2020 Aug; 61():101088. PubMed ID: 32470641
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the development of deubiquitinases inhibitors as antitumor agents.
Zheng LL; Wang LT; Pang YW; Sun LP; Shi L
Eur J Med Chem; 2024 Feb; 266():116161. PubMed ID: 38262120
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes.
Cruz L; Soares P; Correia M
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577547
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
Park J; Cho J; Song EJ
Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of DUBs Regulation in Signaling and Disease.
Li Y; Reverter D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498168
[TBL] [Abstract][Full Text] [Related]
10. The DUB Club: Deubiquitinating Enzymes and Neurodevelopmental Disorders.
Jolly LA; Kumar R; Penzes P; Piper M; Gecz J
Biol Psychiatry; 2022 Oct; 92(8):614-625. PubMed ID: 35662507
[TBL] [Abstract][Full Text] [Related]
11. Identification of substrates for human deubiquitinating enzymes (DUBs): An up-to-date review and a case study for neurodevelopmental disorders.
Elu N; Osinalde N; Ramirez J; Presa N; Rodriguez JA; Prieto G; Mayor U
Semin Cell Dev Biol; 2022 Dec; 132():120-131. PubMed ID: 35042675
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
13. Regulation of proteolysis by human deubiquitinating enzymes.
Eletr ZM; Wilkinson KD
Biochim Biophys Acta; 2014 Jan; 1843(1):114-28. PubMed ID: 23845989
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin specific peptidases and prostate cancer.
Guo Y; Cui S; Chen Y; Guo S; Chen D
PeerJ; 2023; 11():e14799. PubMed ID: 36811009
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy.
Yuan T; Yan F; Ying M; Cao J; He Q; Zhu H; Yang B
Front Pharmacol; 2018; 9():1080. PubMed ID: 30319415
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase inhibition as a cancer therapeutic strategy.
D'Arcy P; Wang X; Linder S
Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
[TBL] [Abstract][Full Text] [Related]
17. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.
Lu L; Jifu C; Xia J; Wang J
Biomed Pharmacother; 2024 Jun; 175():116753. PubMed ID: 38761423
[TBL] [Abstract][Full Text] [Related]
18. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
Bonacci T; Emanuele MJ
Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
[TBL] [Abstract][Full Text] [Related]
19. Assay Systems for Profiling Deubiquitinating Activity.
Cho J; Park J; Kim EE; Song EJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781716
[TBL] [Abstract][Full Text] [Related]
20. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
